23 May 2013
Keywords: Taihua, paclitaxel, APIs, China, Europe
Article | 30 September 2009
The AIM-quoted Chinese pharmaceutical manufacturer Taihua has disclosed initial details of plans for high-margin European sales of the active pharmaceutical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 September 2009
22 May 2013
© 2013 thepharmaletter.com